Active Calls for Collaboration

CSL’s Research Acceleration Initiative aims to fast-track the discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applications, aligned with CSL’s focus areas and modalities, will receive funding of up to $400,000 USD over 2 years.

Focus Areas 2025: Cardiovascular & Renal, Hematology, Transplant & Immunology, Plasma Protein Research, Vaccines, Genetic Medicine, Oral Delivery

Interested researchers are invited to:

• Attend information webinars to learn more about the initiative: 21st January 16:00 pm OR 5th February 11:00 am
• Contact Corina Müller at corina.mueller3@uzh.ch to express interest in applying and to obtain online application submission instructions, to submit a non-confidential, 300-word abstract
• For questions related to IP and confidentiality, please reach out to your Unitectra contact (or mail@unitectra.ch if you don’t have a contact yet).

Deadline: 20th February 2025

More details on the focus areas & link to the webinars can be found here (PDF, 203 KB)

The Novartis Research Foundation promotes offbeat project proposals with its FreeNovation program. It calls on researchers in Switzerland to submit bold, untried project ideas that are hard to fund by conventional programs.  

2025 focus areas:

• Glycobiology
• Therapeutic future of epigenetics
• In vivo biology: the power of the whole organism 

Projects can be funded with up to CHF 220,000 over a period of 18 months.

Deadline: 16 March 2025 

More details on the focus areas and the application process can be found here (PDF, 233 KB)

For support with the application you can contact corina.mueller3@uzh.ch

A nephrology-focused pharmaceutical company is seeking innovative drug discovery concepts and druggable targets specifically for genetic kidney diseases, with a focus on rare conditions. They are also interested in novel drug discovery platforms that can be utilized for genetic kidney disease research. 

Deadline: 21 January 2025

More details on the call can be found here (PDF, 198 KB)

For support with the application you can contact corina.mueller3@uzh.ch. For questions related to IP and confidentiality, please reach out to your Unitectra contact (or mail@unitectra.ch if you don’t have a contact yet)

We are seeking innovative, robust bioassay systems that accurately model neuronal dysfunction in neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).

More details on the call and the application process can be found here

For support with the application you can contact corina.mueller3@uzh.ch. For questions related to IP and confidentiality, please reach out to your Unitectra contact (or mail@unitectra.ch if you don’t have a contact yet)

Didn’t find what you’re looking for? Reach out to corina.mueller3@uzh.ch, and we’ll help you explore tailored options